Examining information in the following urls will assist anyone in better understanding the Codex International Threat to Health Freedom. Urls here are for: fda, fda in international arena, Geneva Codex meeting in June, summary of Geneva Mtg regarding dietary supplements, list of Codex contacts world wide, Information about PharmaPrint, Inc. which is stealing our herbs with the blessing of the World Health Organization, Health Canada,Ministry of Agriculture, Fisheries, Foods (UK), B-6 Banned in UK, Australian Therapeutic Goods Administration.

There are many more urls of this sort which we need to add to the IAHF website. As you find them, please let us know.

It should be noted that the FDA is actively working to harmonize its regulations with those of other countries-- which from a standpoint of health freedom is not good.

1. FDA Home Page
http://www.fda.gov/

2. FDA In the International Arena
http://www.fda.gov/oia/fdaintl.htm

(links to url for FDA Office of International Affairs at:

http://www.fda.gov/opacom/morechoices/oia.html
FDA's Office of International Affairs:

Participates in and coordinates FDA involvement in international harmonization and trade activities:

- GATT and NAFTA implementation committees, i.e. Technical Barriers to Trade, Standards-Related Measures and Sanitary and Phytosanitary Measures

Assists in developing, negotiating and implementing international agreements including Mutual Recognition Agreements (MRAs), and Memoranda of Understanding (MOUs):

3. http://www.fao.org/waicent/faoinfo/economic/esn/codex/cac22e/cac22re5.htm
22nd Codex Executive Committee Meeting- Geneva Switzerland, June 1997

4. Summary of Codex Meeting June 1997 Geneva Regd. Dietary Supplements
http://www.fao.org/WAICENT/faoinfo/economic/esn/codex/vitamin.htm

5. List of Codex Contact Points World Wide
http://www.fao.org/WAICENT/faoinfo/economic/esn/codex/contact/contact.htm

6. PharmaPrint Submits With FDA Its First IND for an Herbal Pharmaceutical
http://biz.yahoo.com/bw/97/08/05/pprt_y000_1.html

PharmaPrint has submitted FDA with an Investigational New Drug Application for Saw Palmetto Extract. They are involved in a joint venture with University of Miami. After they get Saw Palmetto approved as a "drug", how long do you think saw palmetto will continue being available as a dietary supplement? PharmaPrint intends to go right down the list of the world's most popular herbs. Next on their list is St. John's Wort

PharmaPrint has the backing of the WHO. On Dec.4, 1996 they announced the world's first patent on a complex herbal molecule.

"If the clinical trials associated with these submissions are permitted by the FDA and if they perform as expected by PharmaPrint, they could result in important new, natural pharmaceuticals addressing worldwide markets aggregating to more than $19 billion."

"These potential new pharmaceuticals employ PharmaPrint's proprietary technology that, for the first time, makes possible standardization of multimolecule herbal medicines necessary for clinical testing, FDA review and third-party reimbursement. If approved, some of these new pharmaceuticals are expected to be available by prescription and others are expected to be available over the counter."

"The company also announced its goal to submit approximately one IND per quarter during the next three years."

"If the clinical trials associated with these submissions are permitted by the FDA and if they perform as expected by PharmaPrint, they could result in important new, natural pharmaceuticals addressing worldwide markets aggregating to more than $19 billion."

"These potential new pharmaceuticals employ PharmaPrint's proprietary technology that, for the first time, makes possible standardization of multimolecule herbal medicines necessary for clinical testing, FDA review and third-party reimbursement. If approved, some of these new pharmaceuticals are expected to be available by prescription and others are expected to be available over the counter."

"Goal: 11 new pharmaceuticals"

"Chairman and Chief Executive Officer Elliot P. Friedman said: 'The IND submission announced today involves a pharmaceutical derived from the saw palmetto berry intended to address symptoms associated with benign prostate enlargement. The next IND --targeted by PharmaPrint for later in 1997 -- involves a pharmaceutical derived from St. John's wort to address depression.'"

Friedman said subsequent INDs expected by PharmaPrint are proprietary pharmaceuticals derived from the following botanicals: garlic for cholesterol control; bilberry for eye fatigue; milk thistle for liver function; echinacea for symptoms associated with flu; valerian for insomnia; ginger for nausea and motion sickness; black cohosh for post menopausal symptoms; agnus castus for PMS; and mistletoefor certain cancers and HIV.

7. Health Canada
http://www.hwc.ca/query.htm

8. Ministry of Agriculture, Fisheries, Foods (UK)
http://www.maff.gov.uk/search/iatoc.exe

9. B-6 Banned in UK
http://www.maff.gov.uk/inf/newsrel/1997/jul/970704A.HTM

10. Australian Therapeutic Goods Administration
http://www.health.gov.au/tga/

11. TGA Related Legislation
http://www.health.gov.au/tga/legis/legis.htm

12. United States Food, Drug, and Cosmetic Act
http://www.fda.gov/opacom/laws/fdcact/fdctoc.htm

International Advocates for Health Freedom
John C. Hammell, Legislative Advocate
2411 Monroe St.#2 Hollywood, FL 33020 USA
800-333-2553, 954-929-2905, FAX 954-929-0507,
FAX ON DEMAND 954-927-8795,jham@concentric.net
www.iahf.com

Donations Needed